Protease inhibitors
    4.
    发明授权
    Protease inhibitors 失效
    蛋白酶抑制剂

    公开(公告)号:US07071184B2

    公开(公告)日:2006-07-04

    申请号:US10239343

    申请日:2001-03-07

    摘要: The present invention provides C1-6alkyl-4-amino-azepan-3-one protease inhibitors and pharmaceutically acceptable salts, hydrates and solvates thereof which inhibit proteases, including cathepsin K, pharmaceutical compositions of such compounds, novel intermediates of such compounds, and methods for treating diseases of excessive bone loss or cartilage or matrix degradation, including osteoporosis; gingival disease including gingivitis and periodontitis; arthritis, more specifically, osteoarthritis and rheumatoid arthritis; Paget's disease; hypercalcemia of malignancy; and metabolic bone disease; and parasitic diseases, including malaria, by administering to a patient in need thereof one or more compounds of the present invention.

    摘要翻译: 本发明提供C 1-6烷基-4-氨基 - 氮杂-3-酮蛋白酶抑制剂及其药学上可接受的盐,水合物和溶剂合物,其抑制蛋白酶,包括组织蛋白酶K,这些化合物的药物组合物 ,这种化合物的新型中间体,以及用于治疗过度骨丢失或软骨或基质降解(包括骨质疏松症)的疾病的方法; 牙龈疾病包括牙龈炎和牙周炎; 关节炎,更具体地,骨关节炎和类风湿性关节炎; 佩吉特病 恶性高钙血症; 和代谢性骨病; 和寄生虫病,包括疟疾,通过向有需要的患者施用一种或多种本发明的化合物。

    Protease inhibitors
    8.
    发明授权
    Protease inhibitors 失效
    蛋白酶抑制剂

    公开(公告)号:US06596715B1

    公开(公告)日:2003-07-22

    申请号:US10129671

    申请日:2002-05-06

    IPC分类号: C07D41300

    CPC分类号: C07D401/14 C07B2200/05

    摘要: This invention relates to the compound of Formula (I): or a pharmaceutically acceptable salt, hydrate or solvate thereof, which is an inhibitor of cysteine proteases, particularly cathepsin K, and is useful in the treatment of diseases in which inhibition of bone loss or of cartilage degradation is a factor.

    摘要翻译: 本发明涉及式(I)化合物或其药学上可接受的盐,水合物或溶剂化物,其是半胱氨酸蛋白酶,特别是组织蛋白酶K的抑制剂,并且可用于治疗其中抑制骨丢失或 的软骨退化是一个因素。

    Protease inhibitors
    9.
    发明授权
    Protease inhibitors 失效
    蛋白酶抑制剂

    公开(公告)号:US06534498B1

    公开(公告)日:2003-03-18

    申请号:US10129681

    申请日:2002-05-06

    IPC分类号: A61K3155

    摘要: This invention relates to the compound of Formula (I) or a pharmaceutically acceptable salt, hydrate or solvate thereof, which is an inhibitor of cysteine proteases, particularly cathepsin K, and is useful in the treatment of diseases in which inhibition of bone loss or of cartilage degradation is a factor.

    摘要翻译: 本发明涉及式(I)化合物或其药学上可接受的盐,水合物或溶剂合物,其是半胱氨酸蛋白酶,特别是组织蛋白酶K的抑制剂,并且可用于治疗其中抑制骨丢失或 软骨退化是一个因素。